Navigation Links
Chroma to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
Date:11/30/2007

OXFORD, England, Nov. 30 /PRNewswire/ -- Chroma Therapeutics Limited announced today that it will report efficacy data from a Phase I clinical trial of its oral, once-daily experimental cancer therapy CHR-2797 at the forthcoming American Society of Hematology (ASH) meeting. CHR-2797 is the only oral aminopeptidase inhibitor currently in clinical development. The company will also be presenting the results of various preclinical studies. Details of the presentations are as follows:

Abstract # 443: oral presentation

Title: A Phase I Study of CHR-2797, an Orally Active Aminopeptidase

Inhibitor in Elderly and/or Treatment Refractory Patients with Acute

Myeloid Leukemia

Location and timing: Acute Myeloid Leukemias: Therapy, excluding

Transplantation-Novel Therapies, Rooms A411-A412: Monday December 10,

2007, 13:30-15:00 Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

Abstract # 1608, Poster # 762

Title: Cellular Aminopeptidase Inhibition as a Target for the Therapy of

AML by the Novel Agent CHR-2797

Location and timing: Poster Session I, Hall B4: Saturday, December 8,

2007, 17:30-19:30 Eastern Standard Time

Presenter: Dr Chris Jenkins (University Hospital, Cardiff, UK)

Abstract # 2505, Poster # 695

Title: Aminopeptidase Inhibition as a Targeted Treatment Strategy in

Myeloma

Location and timing: Poster Session II, Hall B4: Sunday, December 9,

2007, 18:00-20:00, Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

The ASH posters will be available at the company's website, http://www.chromatherapeutics.com following the above presentations.

Enquiries

Chroma Therapeutics Limited

Ian Nicholson Chief Executive Officer +44 (0)1235 829120'/>"/>

SOURCE Chroma Therapeutics Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 (HealthDay News) -- Scientists have developed ... could potentially change the way the blood infection sepsis ... Biologically Inspired Engineering said their device works outside the ... bacteria, fungi and toxins out of patients, blood. ... dying in intensive care units at least 30 percent ...
(Date:9/17/2014)... Dennis Thompson HealthDay Reporter ... and dieters who turn to artificial sweeteners to soothe ... favors, a new Israeli study suggests. Artificial sweeteners ... no calories, researchers found in human and mouse studies. ... alter the bacteria residing in the intestines in ways ...
(Date:9/17/2014)... In an analysis of genetic information among more than ... has found 23 new genetic variants common differences ... risk for prostate cancer. The so-called "meta-analysis," believed to ... hidden mutations among men in a broad array of ... Latino ancestry. , The meta-analysis combined information from smaller ...
(Date:9/17/2014)... Mercy “topped out” the world’s first ... beam into place. Sister of Mercy Claudia Ward also ... and video of the event, including footage from an ... http://bit.ly/MercyVirtual .) , “The topping out means we are ... thousands of patients regardless of the hour or location,” ...
(Date:9/17/2014)... California (PRWEB) September 17, 2014 ... access connectivity solutions, today announced that it will ... in October 2014. This new offering will provide ... and other Software-as-a-Service applications to enable secure single ... the rise of cloud computing, there has been ...
Breaking Medicine News(10 mins):Health News:'Biospleen' Suggests New Way to Treat Blood Infection 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Large study reveals new genetic variants that raise risk for prostate cancer 2Health News:Mercy Tops Out World's First Virtual Care Center 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2
... reveals that virgin olive oil is the best among vegetable ... the Annals of Internal Medicine.// It says heart disease risk ... first pressing of olives gives virgin olive oil. Refined oil ... polyphenols than the latter. ,The study was conducted ...
... intelligent ways to conquer the ubiquitous problem of the bulge, ... protein rich diet vis a vis carbohydrate or fat laden ... of fewer calories that wards off obesity. ... the quantity of peptide YY (PYY), a hormone that actually ...
... situation can play an important role in inspiring memory. ... conducting a more in-depth research// on the formation of ... very anticipation of a fearful situation can stir up ... event has occurred. ,The researchers explained that ...
... women patients who wish to preserve their modesty for religious ... in Lancashire have asked a Calderdale firm is to make ... patients for protection of their religious beliefs. ... considered the first of its kind to be introduced in ...
... have a decreased risk of developing diabetes, according to ... The study found that// only 8 percent of the ... percent of those on older drugs. ,The ... Norvasc and Coversyl with a beta-blocker and a diuretic. ...
... the American Medical Association finds that despite the existing ... training, or// residency includes shifts that involve working long ... Medical Education (ACGME) say that they must be allowed ... Medical School, and colleagues said that interns reported working ...
Cached Medicine News:Health News:Anticipation Could Have An Intense Effect On Memory 2Health News:Anticipation Could Have An Intense Effect On Memory 3Health News:Burka Style Inter-faith Gowns For Muslim Patients In UK 2
(Date:9/17/2014)... Women everywhere know how frustrating a vaginal ... they,re often also embarrassing and have a way of ... ( http://ph-defense.com ) is a new, over-the-counter product designed ... product. Odor, discharge, and discomfort or ... In many cases, the cause of such problems can ...
(Date:9/17/2014)... N.J. , Sept. 17, 2014   ... details how to implement GS1 Standards to support ... and enhance patient safety and security in the ... Applying GS1 Standards to U.S. Pharmaceutical Supply Chain ... Security Act , was developed in collaboration ...
(Date:9/17/2014)... MILL VALLEY, Calif. , Sept. 17, ... announced a partnership in the fight against sarcoma. ... Sarcoma Alliance Suzanne Renee Leider Memorial Assistance Fund. ... assistance to reimburse sarcoma patients for expenses directly ... sarcoma specialist. Scientific literature reinforces the importance of ...
Breaking Medicine Technology:New Product from Vireo Systems: pH-D Feminine Health Support 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 2Champions Oncology Partners with Sarcoma Alliance to Bring Personalized Treatment Options to Sarcoma Patients 3
... Inc., the global leader in cold chain visibility ... (IATA) has deemed Sensitech,s full range of temperature ... with the 53rd edition of the IATA Dangerous ... the United Nations.   The size and lithium metal ...
...  Online news publication in-PharmaTechnologist.com ... news in key biopharma manufacturing niches. Using the ... of four microsites - Ingredients , Processing , ... - each of which delivers highly targeted news. ...
Cached Medicine Technology:Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This dissector offers dual-action jaws, which are long, tapered, and angled 30 to simplify even difficult laparoscopic dissection....
Smooth, rounded working end manipulates organs less traumatically. Used as a general manipulative instrument....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: